PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Scratch-Stopping therapy boosts skin Patients' quality of life
Symptom relief CompletedThis study tested a behavioral therapy called EMD-U for people with atopic dermatitis (eczema) or prurigo nodularis who scratch severely. 96 adults were randomly assigned to receive either EMD-U plus usual care or usual care alone. The goal was to see if EMD-U improved skin-relat…
Matched conditions: PRURIGO NODULARIS
Phase: NA • Sponsor: Tamar Nijsten • Aim: Symptom relief
Last updated May 26, 2026 05:55 UTC
-
New drug shows promise for relieving uncontrollable itching
Symptom relief CompletedThis study tested an experimental drug called KPL-716 in 240 adults with prurigo nodularis, a skin condition that causes hard, itchy bumps. The goal was to see if the drug could safely reduce itching better than a placebo. Participants received either the drug or a placebo, and t…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated May 26, 2026 05:47 UTC
-
New cream may calm uncontrollable itching in skin disease
Symptom relief CompletedThis study tested a medicated cream (ruxolitinib) in 190 adults with prurigo nodularis, a skin condition causing intense itching and bumps. The goal was to see if the cream safely reduces itch better than a placebo cream. Participants applied the cream for 12 weeks, and researche…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC